Equity Overview
Price & Market Data
Price: $2.09
Daily Change: +$0.0481 / 2.30%
Daily Range: $1.98 - $2.15
Market Cap: $17,641,466
Daily Volume: 13,815
Performance Metrics
1 Week: 3.09%
1 Month: -5.21%
3 Months: -7.41%
6 Months: -20.63%
1 Year: -25.93%
YTD: -35.90%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.